Shantelle Kuria/LinkedIn
Nov 27, 2025, 04:58
Shantelle Kuria – von Willebrand Disease: Complex Protein, Difficult Market
Shantelle Kuria, Master of Science in Molecular Medicine at Imperial College London, posted on LinkedIn:
”Ever cut your finger while cooking… and watched it bleed for a moment before it just… stops?
That tiny, almost forgettable moment is driven by a proetin most people have never heard of: von Willebrand factor (VWF).
A few weeks ago, I was exploring VWF biology in an MSc lecture, at the very same time, I was supporting an early-phase clinical trial in VWD in my CRO role.
Two worlds…academic and operational…aligning around the same protein.
And it made me ask:
- What actually drives innovation in bleeding disorders?
- And why is a rare disease like VWD suddenly gaining strategic momentum across industry?
In the full piece, I unpack:
- Science – why VWF’s chaotic multimer structure matters.
- Early-Phase Reality – why VWD trials are some of the hardest to run.
- Market Shift – how recombinant and engineered designs are reshaping a quiet market.
- IP and Strategy – how manufacturing patents + orphan exclusivity shape who can compete.
Full article here.
(Would love to hear your take on it.)”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day